Children and young people aged 12 to 17 years who are severely immuno-compromised and who have had a third primary dose.
Plant a phobl ifanc 12 i 17 oed sy’n ddifrifol imiwnoataliedig ac sydd wedi cael trydydd dos sylfaenol.